MALIGNANT PLEURAL MESOTHELIOMA
Clinical trials for MALIGNANT PLEURAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PLEURAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for MALIGNANT PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to control rare chest cancer
Disease control OngoingThis early-stage study tests whether combining the immunotherapy drug pembrolizumab with a special type of radiation (IMPRINT) is safe for people with malignant pleural mesothelioma, a rare cancer of the lung lining. Seven participants who have already tried at least one other tr…
Matched conditions: MALIGNANT PLEURAL MESOTHELIOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:41 UTC
-
New combo aims to improve mesothelioma surgery outcomes
Disease control OngoingThis study is for people with a type of lung cancer called malignant pleural mesothelioma that can be removed with surgery. Researchers want to see if giving a combination of the immunotherapy drug nivolumab and chemotherapy before surgery is safe and does not delay the operation…
Matched conditions: MALIGNANT PLEURAL MESOTHELIOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:34 UTC
-
5-Day radiation blast shows promise for rare lung cancer
Disease control OngoingThis study tests a new way to give radiation therapy to people with malignant pleural mesothelioma, a rare cancer of the lung lining. After surgery to remove the tumor, 30 patients receive a high dose of radiation over just 5 days using a precise machine called Tomotherapy. The g…
Matched conditions: MALIGNANT PLEURAL MESOTHELIOMA
Phase: NA • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Disease control
Last updated May 20, 2026 11:59 UTC